Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Levodopa Benserazide Madopar[2] Benserazide,
Levodopa		[2] D00059 ,
D03082 		[6] DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		[16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6
2Madopar----[1] 6
3Madopar 125 mg T, tablets----[1] 6
4Madopar 125 mg, orodispersible tablet----[1] 6
5Madopar 200+50 mg----[1] 6
6Madopar LT----[1] 6
7Madopar monotherapy----[1] 6
8Madopar Tab. 125 or Perkin Tab. 25-100mg----[1] 6
9Madopar® 125----[1] 6
10Madopar® 125 mg T Tablets Levodopa 100 mg Benserazide 25 mg (as benserazide hydrochloride)[2] Benserazide,
Levodopa		[2] D00059 ,
D03082 		[6] DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		[16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6
11Madopar® 250----[1] 6
12Madopar® HBS----[1] 6
13Madopar® HBS 125----[1] 6